ReNeuron Comments on Research Highlighting Contamination of Certain Stem Cell Lines
Related News: Stem Cell CompaniesReNeuron, an UK-based stem cell research and development company, has noted the recent publication in Nature Medicine of findings by US researchers indicating that human embryonic stem cell lines (ESCs) have been contaminated by non-human molecules derived from the animal feeder cell layers used to grow the cells.
The Company has received a number of enquiries regarding the potential impact of these findings on its activities.
ReNeuron's stem cell lines are derived from somatic, or lineage-restricted, stem cells rather than earlier-stage ESCs, and are grown in the absence of animal feeder layers. The Company's c-mycERTAM technology platform allows unlimited controlled expansion of these stem cell lines from individual human cells.
ReNeuron's lead stem cell product, ReN001, is currently in late pre-clinical development as a treatment for patients who have suffered disability after stroke. ReN001 has been shown to be safe and efficacious when transplanted into pre-clinical models of chronic stroke, and the Company expects to commence clinical trials with ReN001 in early 2006.
Posted on January 27, 2005 12:54 PM
Trackback Pings
TrackBack URL for this entry:
http://www.stemnews.com/mt/mt-tb.cgi/58